HEDIS® Results
Molina Dual Options TX STAR+PLUS MMP HEDIS® Annual Rates.
Molina Dual Options’ STAR+PLUS MMP scores for the past two years are below. You can see how Molina Dual Options STAR+PLUS MMP performs compared to our target goal.
|
Measure (H8197) |
2022 |
2023 |
Goal |
|
Antidepressant Medication Management (AMM) Effective Continuation Phase |
61.32% |
48.58% |
70.21% |
|
Breast Cancer Screening (BCS) |
52.79% |
55.04% |
71.00% |
|
Care for Older Adults (COA) Medication Review |
77.13% |
77.86% |
93.00% |
|
Care for Older Adults (COA) Pain Screening |
77.13% |
76.64% |
91.00% |
|
Colorectal Cancer Screening (COL) |
50.36% |
47.20% |
71.00% |
|
Diabetes Care Blood Sugar Controlled (HBD) |
61.80% |
63.50% |
80.00% |
|
Diabetes Care Eye Exam Total (EED) |
63.50% |
62.29% |
73.00% |
|
Controlling High Blood Pressure (CBP) |
64.72% |
66.67% |
74.00% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 30-Day Rate Total |
58.54% |
61.35% |
60.54% |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) Initiation of SUD Treatment Total |
35.55% |
47.20% |
44.70% |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) Engagement of SUD Treatment Total |
3.52% |
4.92% |
7.4%% |
|
Osteoporosis Management in Women Who Had a Fracture (OMW) |
NA |
NA |
55.00% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio (Ages 18-64) |
103.03% |
106.73% |
≤ 92.56% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio (Ages 65+) |
102.99% |
112.15% |
≤ 95.74% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Total |
84.32% |
82.11% |
88.09% |
|
Transitions of Care (TRC) Medication Reconciliation Post-Discharge |
18.00% |
22.38% |
68.00% |
|
Measure (H8423) |
2023 |
Goal |
|
Antidepressant Medication Management (AMM) Effective Continuation Phase |
54.55% |
70.21% |
|
Breast Cancer Screening (BCS) |
51.83% |
71.00% |
|
Care for Older Adults (COA) Medication Review |
72.99% |
93.00% |
|
Care for Older Adults (COA) Pain Screening |
69.34% |
91.00% |
|
Colorectal Cancer Screening (COL) |
41.98% |
71.00% |
|
Diabetes Care Blood Sugar Controlled (HBD) |
60.81% |
80.00% |
|
Diabetes Care Eye Exam Total (EED) |
72.65% |
73.00% |
|
Controlling High Blood Pressure (CBP) |
68.41% |
74.00% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 30-Day Rate Total |
NA |
60.54% |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) Initiation of SUD Treatment Total |
16.67% |
44.70% |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) Engagement of SUD Treatment Total |
0.00% |
7.4%% |
|
Osteoporosis Management in Women Who Had a Fracture (OMW) |
NA |
55.00% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio (Ages 18-64) |
50.26% |
≤ 92.56% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio (Ages 65+) |
98.75% |
≤ 95.74% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Total |
76.27% |
88.09% |
|
Transitions of Care (TRC) Medication Reconciliation Post-Discharge |
44.44% |
68.00% |
Molina Dual Options STAR+PLUS MMP is a health plan that contracts with both Medicare and Texas Medicaid to provide benefits of both programs to enrollees.
Molina Healthcare complies with applicable Federal civil rights laws and does not discriminate on the basis of race, ethnicity, national origin, religion, gender, sex, age, mental or physical disability, health status, receipt of healthcare, claims experience, medical history, genetic information, evidence of insurability, geographic location.
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate
H8197_24_4496_TXMMPHEDISRateWeb